insufficient data
| T vs. C | paclitaxel | doxorubicin | pembrolizumab plus lenvatinib | lenvatinib in association |
| paclitaxel | --- | NA | NA | NA |
| doxorubicin | NA | --- | NA | NA |
| pembrolizumab plus lenvatinib | NA | NA | --- | NA |
| lenvatinib in association | NA | NA | NA | --- |
pathologies: 77
- treatments: 1477
result logic
